SIMILAR PATTERNS OF AMINO ACIDS FOR 6G9B_A_IXXA609
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bg6 | N-(1-D-CARBOXYLETHYL)-L-NORVALINEDEHYDROGENASE (Arthrobactersp. 1C) |
PF02317(Octopine_DH)PF02558(ApbA) | 5 | ILE A 244LEU A 308VAL A 358LEU A 190LEU A 250 | None | 1.08A | 6g9bA-1bg6A:0.06g9bB-1bg6A:0.0 | 6g9bA-1bg6A:13.456g9bB-1bg6A:13.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jg5 | GTP CYCLOHYDROLASE IFEEDBACK REGULATORYPROTEIN (Rattusnorvegicus) |
PF06399(GFRP) | 4 | LEU A 27VAL A 55LEU A 59LEU A 80 | None | 0.75A | 6g9bA-1jg5A:undetectable6g9bB-1jg5A:undetectable | 6g9bA-1jg5A:27.066g9bB-1jg5A:19.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jl5 | OUTER PROTEIN YOPM (Yersinia pestis) |
PF12468(TTSSLRR) | 4 | LEU A1312VAL A1284LEU A1302LEU A1299 | None | 0.54A | 6g9bA-1jl5A:0.06g9bB-1jl5A:undetectable | 6g9bA-1jl5A:10.476g9bB-1jl5A:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jl5 | OUTER PROTEIN YOPM (Yersinia pestis) |
PF12468(TTSSLRR) | 4 | VAL A1118LEU A1123LEU A1143LEU A1109 | None | 0.75A | 6g9bA-1jl5A:0.06g9bB-1jl5A:undetectable | 6g9bA-1jl5A:10.476g9bB-1jl5A:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1koa | TWITCHIN (Caenorhabditiselegans) |
PF00069(Pkinase)PF07679(I-set) | 4 | ILE A6174LEU A6177VAL A6047LEU A6064 | None | 0.66A | 6g9bA-1koaA:undetectable6g9bB-1koaA:0.0 | 6g9bA-1koaA:10.156g9bB-1koaA:10.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1odi | PURINE NUCLEOSIDEPHOSPHORYLASE (Thermusthermophilus) |
PF01048(PNP_UDP_1) | 4 | ILE A 199VAL A 58LEU A 18LEU A 233 | None | 0.70A | 6g9bA-1odiA:0.06g9bB-1odiA:0.0 | 6g9bA-1odiA:16.036g9bB-1odiA:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p9n | MOLYBDOPTERIN-GUANINE DINUCLEOTIDEBIOSYNTHESIS PROTEINB (Escherichiacoli) |
PF03205(MobB) | 5 | ILE A 151LEU A 18LEU A 157LEU A 149LEU A 5 | None | 1.15A | 6g9bA-1p9nA:0.06g9bB-1p9nA:0.0 | 6g9bA-1p9nA:18.506g9bB-1p9nA:16.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q5a | EP-CADHERIN (Mus musculus) |
PF00028(Cadherin) | 4 | ILE A 261LEU A 298LEU A 282LEU A 288 | None | 0.00A | 6g9bA-1q5aA:undetectable6g9bB-1q5aA:0.0 | 6g9bA-1q5aA:7.126g9bB-1q5aA:6.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tte | UBIQUITIN-CONJUGATING ENZYME E2-24 KDA (Saccharomycescerevisiae) |
PF00179(UQ_con)PF09288(UBA_3) | 4 | ILE A 91LEU A 92VAL A 54LEU A 102 | None | 0.69A | 6g9bA-1tteA:0.06g9bB-1tteA:0.0 | 6g9bA-1tteA:15.096g9bB-1tteA:15.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1u0n | PLATELETGLYCOPROTEIN IB (Homo sapiens) |
PF01462(LRRNT)PF13855(LRR_8) | 4 | LEU D 167LEU D 153LEU D 150LEU D 115 | None | 0.72A | 6g9bA-1u0nD:0.06g9bB-1u0nD:0.0 | 6g9bA-1u0nD:17.626g9bB-1u0nD:17.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vhz | ADP COMPOUNDSHYDROLASE NUDE (Escherichiacoli) |
PF00293(NUDIX) | 4 | LEU A 158VAL A 53LEU A 60LEU A 152 | None | 0.74A | 6g9bA-1vhzA:undetectable6g9bB-1vhzA:0.0 | 6g9bA-1vhzA:16.326g9bB-1vhzA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xeu | INTERNALIN C (Listeriamonocytogenes) |
PF08191(LRR_adjacent)PF12354(Internalin_N)PF12799(LRR_4) | 4 | LEU A 121VAL A 126LEU A 90LEU A 134 | None | 0.72A | 6g9bA-1xeuA:undetectable6g9bB-1xeuA:undetectable | 6g9bA-1xeuA:16.356g9bB-1xeuA:14.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bex | RIBONUCLEASEINHIBITOR (Homo sapiens) |
PF13516(LRR_6) | 4 | LEU A 360VAL A 319LEU A 345LEU A 342 | None | 0.62A | 6g9bA-2bexA:undetectable6g9bB-2bexA:undetectable | 6g9bA-2bexA:12.096g9bB-2bexA:11.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bgh | VINORINE SYNTHASE (Rauvolfiaserpentina) |
PF02458(Transferase) | 4 | LEU A 71VAL A 156LEU A 140LEU A 172 | None | 0.74A | 6g9bA-2bghA:undetectable6g9bB-2bghA:undetectable | 6g9bA-2bghA:12.506g9bB-2bghA:11.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2id5 | LEUCINE RICH REPEATNEURONAL 6A (Homo sapiens) |
PF07679(I-set)PF13306(LRR_5)PF13855(LRR_8) | 5 | LEU A 172VAL A 135LEU A 157LEU A 154LEU A 119 | None | 0.70A | 6g9bA-2id5A:undetectable6g9bB-2id5A:undetectable | 6g9bA-2id5A:10.936g9bB-2id5A:11.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2idg | HYPOTHETICAL PROTEINAF0160 (Archaeoglobusfulgidus) |
PF02613(Nitrate_red_del) | 5 | ILE A 25LEU A 19VAL A 148LEU A 144LEU A 95 | None | 1.04A | 6g9bA-2idgA:undetectable6g9bB-2idgA:undetectable | 6g9bA-2idgA:18.296g9bB-2idgA:15.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iun | AVIAN ADENOVIRUSCELO LONG FIBRE (Fowlaviadenovirus A) |
PF16812(AdHead_fibreRBD) | 4 | ILE A 719VAL A 655LEU A 755LEU A 618 | None | 0.73A | 6g9bA-2iunA:undetectable6g9bB-2iunA:undetectable | 6g9bA-2iunA:16.066g9bB-2iunA:15.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jam | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE 1G (Homo sapiens) |
PF00069(Pkinase) | 4 | ILE A 255LEU A 258VAL A 128LEU A 145 | None | 0.72A | 6g9bA-2jamA:undetectable6g9bB-2jamA:undetectable | 6g9bA-2jamA:15.496g9bB-2jamA:15.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mbr | URIDINEDIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMINEREDUCTASE (Escherichiacoli) |
PF01565(FAD_binding_4)PF02873(MurB_C) | 4 | LEU A 129VAL A 83LEU A 178LEU A 180 | None | 0.75A | 6g9bA-2mbrA:undetectable6g9bB-2mbrA:undetectable | 6g9bA-2mbrA:15.466g9bB-2mbrA:11.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qgq | PROTEIN TM_1862 (Thermotogamaritima) |
PF04055(Radical_SAM) | 4 | ILE A 417LEU A 374VAL A 290LEU A 366 | None | 0.67A | 6g9bA-2qgqA:undetectable6g9bB-2qgqA:undetectable | 6g9bA-2qgqA:15.056g9bB-2qgqA:14.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qqk | NEUROPILIN-2 (Homo sapiens) |
PF00431(CUB)PF00754(F5_F8_type_C) | 4 | VAL A 407LEU A 339LEU A 398LEU A 422 | None | 0.70A | 6g9bA-2qqkA:undetectable6g9bB-2qqkA:undetectable | 6g9bA-2qqkA:10.046g9bB-2qqkA:11.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r6r | CELL DIVISIONPROTEIN FTSZ (Aquifexaeolicus) |
PF00091(Tubulin)PF12327(FtsZ_C) | 4 | LEU 1 219VAL 1 319LEU 1 246LEU 1 144 | None | 0.46A | 6g9bA-2r6r1:undetectable6g9bB-2r6r1:undetectable | 6g9bA-2r6r1:11.506g9bB-2r6r1:13.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ya2 | PUTATIVE ALKALINEAMYLOPULLULANASE (Streptococcuspneumoniae) |
PF00128(Alpha-amylase)PF02922(CBM_48) | 4 | ILE A 242LEU A 241LEU A 180LEU A 170 | None | 0.73A | 6g9bA-2ya2A:undetectable6g9bB-2ya2A:undetectable | 6g9bA-2ya2A:7.566g9bB-2ya2A:8.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yru | STEROID RECEPTOR RNAACTIVATOR 1 (Mus musculus) |
PF07304(SRA1) | 5 | LEU A 57VAL A 102LEU A 48LEU A 19LEU A 68 | None | 1.05A | 6g9bA-2yruA:undetectable6g9bB-2yruA:undetectable | 6g9bA-2yruA:23.426g9bB-2yruA:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z81 | TOLL-LIKE RECEPTOR2, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Mus musculus) |
PF11921(DUF3439)PF13306(LRR_5)PF13516(LRR_6)PF13855(LRR_8) | 4 | LEU A 194LEU A 179LEU A 176LEU A 139 | None | 0.71A | 6g9bA-2z81A:undetectable6g9bB-2z81A:undetectable | 6g9bA-2z81A:8.936g9bB-2z81A:9.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z81 | TOLL-LIKE RECEPTOR2, VARIABLELYMPHOCYTE RECEPTORB (Eptatretusburgeri;Mus musculus) |
PF11921(DUF3439)PF13306(LRR_5)PF13516(LRR_6)PF13855(LRR_8) | 4 | LEU A 497VAL A 451LEU A 489LEU A 462 | None | 0.73A | 6g9bA-2z81A:undetectable6g9bB-2z81A:undetectable | 6g9bA-2z81A:8.936g9bB-2z81A:9.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zrr | MUNDTICIN KSIMMUNITY PROTEIN (Enterococcusmundtii) |
PF08951(EntA_Immun) | 4 | LEU A 77LEU A 37LEU A 88MET A 89 | None | 0.74A | 6g9bA-2zrrA:undetectable6g9bB-2zrrA:undetectable | 6g9bA-2zrrA:23.146g9bB-2zrrA:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bz5 | INTERNALIN-J (Listeriamonocytogenes) |
PF12799(LRR_4) | 4 | LEU A 257LEU A 247LEU A 244LEU A 215 | None | 0.72A | 6g9bA-3bz5A:undetectable6g9bB-3bz5A:undetectable | 6g9bA-3bz5A:11.856g9bB-3bz5A:10.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cvr | INVASION PLASMIDANTIGEN (Shigellaflexneri) |
PF12468(TTSSLRR)PF14496(NEL) | 4 | LEU A 115LEU A 105LEU A 102LEU A 74 | None | 0.61A | 6g9bA-3cvrA:undetectable6g9bB-3cvrA:undetectable | 6g9bA-3cvrA:8.956g9bB-3cvrA:8.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3daw | TWINFILIN-1 (Mus musculus) |
PF00241(Cofilin_ADF) | 5 | ILE B 282LEU B 279VAL B 201LEU B 190LEU B 287 | None | 1.50A | 6g9bA-3dawB:undetectable6g9bB-3dawB:undetectable | 6g9bA-3dawB:18.406g9bB-3dawB:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e4e | CYTOCHROME P450 2E1 (Homo sapiens) |
PF00067(p450) | 4 | LEU A 455LEU A 312LEU A 487LEU A 154 | None | 0.72A | 6g9bA-3e4eA:0.06g9bB-3e4eA:0.1 | 6g9bA-3e4eA:11.426g9bB-3e4eA:12.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g06 | SSPH2 (LEUCINE-RICHREPEAT PROTEIN) (Salmonellaenterica) |
PF14496(NEL) | 4 | LEU A 257LEU A 247LEU A 244LEU A 216 | None | 0.60A | 6g9bA-3g06A:undetectable6g9bB-3g06A:undetectable | 6g9bA-3g06A:9.436g9bB-3g06A:8.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g06 | SSPH2 (LEUCINE-RICHREPEAT PROTEIN) (Salmonellaenterica) |
PF14496(NEL) | 4 | LEU A 277LEU A 267LEU A 264LEU A 237 | None | 0.73A | 6g9bA-3g06A:undetectable6g9bB-3g06A:undetectable | 6g9bA-3g06A:9.436g9bB-3g06A:8.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i9v | NADH-QUINONEOXIDOREDUCTASESUBUNIT 3 (Thermusthermophilus) |
PF00384(Molybdopterin)PF01568(Molydop_binding)PF04879(Molybdop_Fe4S4)PF10588(NADH-G_4Fe-4S_3)PF13510(Fer2_4) | 4 | LEU 3 477VAL 3 532LEU 3 507LEU 3 512 | None | 0.74A | 6g9bA-3i9v3:undetectable6g9bB-3i9v3:undetectable | 6g9bA-3i9v3:6.746g9bB-3i9v3:7.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jru | PROBABLE CYTOSOLAMINOPEPTIDASE (Xanthomonasoryzae) |
no annotation | 4 | VAL B 77LEU B 64LEU B 67LEU B 49 | None | 0.69A | 6g9bA-3jruB:undetectable6g9bB-3jruB:undetectable | 6g9bA-3jruB:10.846g9bB-3jruB:10.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o4z | TELOMERE LENGTHREGULATION PROTEINTEL2 (Saccharomycescerevisiae) |
PF10193(Telomere_reg-2) | 4 | ILE A 250VAL A 237LEU A 241LEU A 270 | None | 0.75A | 6g9bA-3o4zA:undetectable6g9bB-3o4zA:undetectable | 6g9bA-3o4zA:10.026g9bB-3o4zA:8.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 4 | LEU A 142VAL A 245LEU A 217LEU A 219 | None | 0.69A | 6g9bA-3o5dA:undetectable6g9bB-3o5dA:undetectable | 6g9bA-3o5dA:15.216g9bB-3o5dA:14.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q6v | BETA-LACTAMASE (Serratiafonticola) |
PF00753(Lactamase_B) | 4 | ILE A 222LEU A 223LEU A 249LEU A 192 | None | 0.70A | 6g9bA-3q6vA:undetectable6g9bB-3q6vA:undetectable | 6g9bA-3q6vA:16.456g9bB-3q6vA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qsv | MOTHERS AGAINSTDECAPENTAPLEGICHOMOLOG 4 (Mus musculus) |
PF03165(MH1) | 5 | ILE A 19LEU A 23VAL A 128LEU A 57LEU A 47 | None | 1.24A | 6g9bA-3qsvA:undetectable6g9bB-3qsvA:undetectable | 6g9bA-3qsvA:21.546g9bB-3qsvA:16.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3s88 | ENVELOPEGLYCOPROTEIN (Sudanebolavirus) |
PF01611(Filo_glycop)no annotation | 4 | LEU I 43VAL I 66LEU I 184LEU J 515 | None | 0.68A | 6g9bA-3s88I:28.36g9bB-3s88I:undetectable | 6g9bA-3s88I:74.396g9bB-3s88I:14.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3stj | PROTEASE DEGQ (Escherichiacoli) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 4 | LEU A 301VAL A 329LEU A 316LEU A 318 | None | 0.66A | 6g9bA-3stjA:undetectable6g9bB-3stjA:undetectable | 6g9bA-3stjA:16.236g9bB-3stjA:13.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t51 | CATION EFFLUX SYSTEMPROTEIN CUSB (Escherichiacoli) |
PF00529(HlyD)PF16576(HlyD_D23) | 4 | VAL B 355LEU B 371LEU B 325LEU B 332 | None | 0.75A | 6g9bA-3t51B:undetectable6g9bB-3t51B:undetectable | 6g9bA-3t51B:19.926g9bB-3t51B:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3txa | CELL WALL SURFACEANCHOR FAMILYPROTEIN (Streptococcusagalactiae) |
PF00092(VWA) | 4 | ILE A 643VAL A 595LEU A 663LEU A 205 | None | 0.68A | 6g9bA-3txaA:0.46g9bB-3txaA:undetectable | 6g9bA-3txaA:7.406g9bB-3txaA:8.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ucq | AMYLOSUCRASE (Deinococcusgeothermalis) |
PF00128(Alpha-amylase) | 4 | ILE A 170LEU A 112LEU A 161LEU A 172 | None | 0.69A | 6g9bA-3ucqA:undetectable6g9bB-3ucqA:0.5 | 6g9bA-3ucqA:7.506g9bB-3ucqA:9.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vqr | PUTATIVEOXIDOREDUCTASE (Aeropyrumpernix) |
PF01266(DAO) | 4 | ILE A 243LEU A 241VAL A 184LEU A 237 | EDO A1004 (-4.4A)NoneFAD A1001 (-3.9A)FAD A1001 ( 4.3A) | 0.71A | 6g9bA-3vqrA:undetectable6g9bB-3vqrA:undetectable | 6g9bA-3vqrA:11.876g9bB-3vqrA:10.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w5i | FERROUS IRONTRANSPORT PROTEIN B (Gallionellacapsiferriformans) |
PF02421(FeoB_N) | 4 | LEU A 98LEU A 55LEU A 105MET A 107 | None | 0.73A | 6g9bA-3w5iA:undetectable6g9bB-3w5iA:undetectable | 6g9bA-3w5iA:18.526g9bB-3w5iA:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wy7 | 8-AMINO-7-OXONONANOATE SYNTHASE (Mycolicibacteriumsmegmatis) |
PF00155(Aminotran_1_2) | 4 | LEU A 361VAL A 336LEU A 40LEU A 355 | None | 0.73A | 6g9bA-3wy7A:undetectable6g9bB-3wy7A:undetectable | 6g9bA-3wy7A:11.766g9bB-3wy7A:11.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ays | AMYLOSUCRASE (Deinococcusradiodurans) |
PF00128(Alpha-amylase) | 4 | ILE A 166LEU A 108LEU A 157LEU A 168 | None | 0.72A | 6g9bA-4aysA:undetectable6g9bB-4aysA:undetectable | 6g9bA-4aysA:8.976g9bB-4aysA:9.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckm | SAS-6 (Leishmaniamajor) |
PF16531(SAS-6_N) | 4 | ILE A 263VAL A 139LEU A 249LEU A 135 | None | 0.74A | 6g9bA-4ckmA:undetectable6g9bB-4ckmA:undetectable | 6g9bA-4ckmA:19.886g9bB-4ckmA:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ckn | SAS-6 (Leishmaniamajor) |
PF16531(SAS-6_N) | 5 | ILE A 263VAL A 139LEU A 232LEU A 249LEU A 135 | None | 0.96A | 6g9bA-4cknA:undetectable6g9bB-4cknA:undetectable | 6g9bA-4cknA:14.756g9bB-4cknA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cp6 | CHOLINE BINDINGPROTEIN PCPA (Streptococcuspneumoniae) |
PF13306(LRR_5) | 4 | ILE A 346LEU A 324VAL A 358LEU A 368 | None | 0.72A | 6g9bA-4cp6A:undetectable6g9bB-4cp6A:undetectable | 6g9bA-4cp6A:13.516g9bB-4cp6A:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4es6 | UROPORPHYRINOGEN-IIISYNTHASE (Pseudomonasaeruginosa) |
PF02602(HEM4) | 4 | VAL A 27LEU A 6LEU A 8LEU A 244 | NoneNone CL A 301 ( 4.6A)None | 0.69A | 6g9bA-4es6A:undetectable6g9bB-4es6A:undetectable | 6g9bA-4es6A:15.516g9bB-4es6A:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glp | MONOCYTEDIFFERENTIATIONANTIGEN CD14 (Homo sapiens) |
PF13516(LRR_6) | 4 | ILE A 128LEU A 106LEU A 123LEU A 168 | None | 0.68A | 6g9bA-4glpA:undetectable6g9bB-4glpA:undetectable | 6g9bA-4glpA:13.096g9bB-4glpA:12.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hh5 | PUTATIVE TYPE VISECRETION PROTEIN (Escherichiacoli) |
PF02861(Clp_N) | 5 | LEU A 55VAL A 129LEU A 44LEU A 73LEU A 138 | BR A 201 ( 4.4A)NoneNoneNoneNone | 1.04A | 6g9bA-4hh5A:undetectable6g9bB-4hh5A:undetectable | 6g9bA-4hh5A:17.906g9bB-4hh5A:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j7m | PROTEIN DOM3Z (Mus musculus) |
PF08652(RAI1) | 4 | VAL A 129LEU A 124LEU A 117LEU A 107 | None | 0.74A | 6g9bA-4j7mA:undetectable6g9bB-4j7mA:undetectable | 6g9bA-4j7mA:13.506g9bB-4j7mA:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4keg | MALTOSE-BINDINGPERIPLASMIC/PALATELUNG AND NASALEPITHELIUM CLONEFUSION PROTEIN (Escherichiacoli;Homo sapiens) |
PF01273(LBP_BPI_CETP)PF13416(SBP_bac_8) | 4 | LEU A1234VAL A1131LEU A1055LEU A1059 | None | 0.72A | 6g9bA-4kegA:undetectable6g9bB-4kegA:undetectable | 6g9bA-4kegA:9.676g9bB-4kegA:11.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kny | KDP OPERONTRANSCRIPTIONALREGULATORY PROTEINKDPE (Escherichiacoli) |
PF00072(Response_reg)PF00486(Trans_reg_C) | 5 | ILE A 105LEU A 108VAL A 4LEU A 21LEU A 116 | None | 1.29A | 6g9bA-4knyA:0.86g9bB-4knyA:undetectable | 6g9bA-4knyA:18.136g9bB-4knyA:15.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nkh | E3 UBIQUITIN-PROTEINLIGASE SSPH1 (Salmonellaenterica) |
no annotation | 4 | LEU A 252LEU A 241LEU A 238LEU A 210 | None | 0.62A | 6g9bA-4nkhA:undetectable6g9bB-4nkhA:undetectable | 6g9bA-4nkhA:15.196g9bB-4nkhA:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nkh | E3 UBIQUITIN-PROTEINLIGASE SSPH1 (Salmonellaenterica) |
no annotation | 4 | LEU A 272LEU A 262LEU A 259LEU A 231 | None | 0.71A | 6g9bA-4nkhA:undetectable6g9bB-4nkhA:undetectable | 6g9bA-4nkhA:15.196g9bB-4nkhA:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o1o | RIBONUCLEASE L (Sus scrofa) |
PF00069(Pkinase)PF06479(Ribonuc_2-5A)PF12796(Ank_2)PF13857(Ank_5) | 4 | ILE A 488LEU A 498LEU A 483LEU A 574 | None | 0.64A | 6g9bA-4o1oA:undetectable6g9bB-4o1oA:undetectable | 6g9bA-4o1oA:9.606g9bB-4o1oA:9.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oav | PROTEIN (RNASE L) (Homo sapiens) |
PF00069(Pkinase)PF06479(Ribonuc_2-5A)PF12796(Ank_2)PF13857(Ank_5) | 4 | ILE B 491LEU B 501LEU B 486LEU B 577 | None | 0.66A | 6g9bA-4oavB:undetectable6g9bB-4oavB:undetectable | 6g9bA-4oavB:7.786g9bB-4oavB:7.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ofx | CYSTATHIONINEBETA-SYNTHASE (Coxiellaburnetii) |
PF00291(PALP) | 5 | VAL A 291LEU A 29LEU A 25LEU A 257MET A 253 | None | 1.49A | 6g9bA-4ofxA:undetectable6g9bB-4ofxA:undetectable | 6g9bA-4ofxA:12.506g9bB-4ofxA:14.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4peq | RIBONUCLEASE/ANGIOGENIN INHIBITOR 1 (Bos taurus) |
PF13516(LRR_6) | 4 | LEU B 356VAL B 315LEU B 341LEU B 338 | None | 0.70A | 6g9bA-4peqB:undetectable6g9bB-4peqB:undetectable | 6g9bA-4peqB:11.906g9bB-4peqB:10.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4per | RIBONUCLEASEINHIBITOR (Gallus gallus) |
PF13516(LRR_6) | 4 | LEU A 356VAL A 315LEU A 341LEU A 338 | None | 0.65A | 6g9bA-4perA:undetectable6g9bB-4perA:undetectable | 6g9bA-4perA:13.886g9bB-4perA:11.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4psj | OR464 (syntheticconstruct) |
PF12354(Internalin_N)PF13516(LRR_6)PF13855(LRR_8) | 4 | LEU A 262LEU A 241LEU A 238LEU A 203 | None | 0.71A | 6g9bA-4psjA:undetectable6g9bB-4psjA:undetectable | 6g9bA-4psjA:14.136g9bB-4psjA:14.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qds | NEUROPILIN-2 (Homo sapiens) |
PF00754(F5_F8_type_C) | 4 | VAL A 407LEU A 339LEU A 398LEU A 422 | None | 0.71A | 6g9bA-4qdsA:undetectable6g9bB-4qdsA:undetectable | 6g9bA-4qdsA:18.426g9bB-4qdsA:20.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u09 | LIC12759 (Leptospirainterrogans) |
PF13855(LRR_8) | 4 | LEU A 171LEU A 161LEU A 158LEU A 125 | None | 0.70A | 6g9bA-4u09A:undetectable6g9bB-4u09A:undetectable | 6g9bA-4u09A:14.136g9bB-4u09A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u09 | LIC12759 (Leptospirainterrogans) |
PF13855(LRR_8) | 4 | VAL A 198LEU A 204LEU A 227LEU A 186 | None | 0.73A | 6g9bA-4u09A:undetectable6g9bB-4u09A:undetectable | 6g9bA-4u09A:14.136g9bB-4u09A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uop | LIPOTEICHOIC ACIDPRIMASE (Listeriamonocytogenes) |
PF00884(Sulfatase) | 4 | ILE A 534LEU A 535VAL A 449LEU A 492 | None1PE A1611 ( 4.7A)NoneNone | 0.74A | 6g9bA-4uopA:undetectable6g9bB-4uopA:undetectable | 6g9bA-4uopA:12.546g9bB-4uopA:10.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b0n | E3 UBIQUITIN-PROTEINLIGASE IPAH9.8 (Shigellaflexneri) |
PF12468(TTSSLRR) | 4 | LEU A 112VAL A 84LEU A 102LEU A 99 | None | 0.73A | 6g9bA-5b0nA:undetectable6g9bB-5b0nA:undetectable | 6g9bA-5b0nA:19.786g9bB-5b0nA:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e5o | I-SMAMI LAGLIDADGENDONUCLEASE (Sordariamacrospora) |
PF00961(LAGLIDADG_1) | 4 | ILE A 185LEU A 186LEU A 200MET A 297 | None | 0.70A | 6g9bA-5e5oA:undetectable6g9bB-5e5oA:undetectable | 6g9bA-5e5oA:12.756g9bB-5e5oA:12.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5es9 | LINEAR GRAMICIDINSYNTHETASE SUBUNIT A (Brevibacillusparabrevis) |
PF00501(AMP-binding)PF00550(PP-binding)PF00551(Formyl_trans_N)PF13193(AMP-binding_C) | 4 | VAL A 673LEU A 678LEU A 616LEU A 612 | None | 0.63A | 6g9bA-5es9A:undetectable6g9bB-5es9A:undetectable | 6g9bA-5es9A:7.516g9bB-5es9A:9.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5f1b | GP1 (Zaireebolavirus) |
PF01611(Filo_glycop) | 4 | LEU A 43VAL A 66LEU A 184LEU A 186 | None | 0.27A | 6g9bA-5f1bA:23.16g9bB-5f1bA:undetectable | 6g9bA-5f1bA:98.706g9bB-5f1bA:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fg3 | PROBABLE TRANSLATIONINITIATION FACTORIF-2 (Aeropyrumpernix) |
PF00009(GTP_EFTU)PF03144(GTP_EFTU_D2)PF11987(IF-2)PF14578(GTP_EFTU_D4) | 4 | VAL A 262LEU A 97LEU A 93LEU A 84 | None | 0.64A | 6g9bA-5fg3A:undetectable6g9bB-5fg3A:undetectable | 6g9bA-5fg3A:8.756g9bB-5fg3A:10.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fms | INTRAFLAGELLARTRANSPORT PROTEIN 52HOMOLOG (Mus musculus) |
PF09822(ABC_transp_aux) | 5 | VAL A 237LEU A 241LEU A 55LEU A 214MET A 86 | None | 1.13A | 6g9bA-5fmsA:undetectable6g9bB-5fmsA:undetectable | 6g9bA-5fmsA:17.126g9bB-5fmsA:14.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gnd | PUTATIVE SERINEPROTEASE HHOA (Synechocystissp. PCC 6803) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 4 | LEU A 356VAL A 384LEU A 371LEU A 373 | None | 0.69A | 6g9bA-5gndA:undetectable6g9bB-5gndA:undetectable | 6g9bA-5gndA:14.516g9bB-5gndA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h9x | BETA-1,3-GLUCANASE (Paenibacillusbarengoltzii) |
PF16483(Glyco_hydro_64) | 4 | ILE A 182VAL A 235LEU A 200LEU A 415 | None | 0.65A | 6g9bA-5h9xA:undetectable6g9bB-5h9xA:undetectable | 6g9bA-5h9xA:11.906g9bB-5h9xA:9.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hj3 | ENVELOPEGLYCOPROTEIN (Ebola virus sp.) |
PF01611(Filo_glycop) | 4 | LEU C 43VAL C 66LEU C 184LEU C 186 | None | 0.35A | 6g9bA-5hj3C:23.46g9bB-5hj3C:undetectable | 6g9bA-5hj3C:95.126g9bB-5hj3C:17.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5htp | PROBABLE SUGARKINASE (Synechococcuselongatus) |
PF02782(FGGY_C) | 4 | ILE A 138LEU A 77LEU A 132LEU A 182 | None | 0.74A | 6g9bA-5htpA:undetectable6g9bB-5htpA:undetectable | 6g9bA-5htpA:10.676g9bB-5htpA:10.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i7k | BPI FOLD-CONTAININGFAMILY A MEMBER 1 (Homo sapiens) |
PF01273(LBP_BPI_CETP) | 4 | LEU A 234VAL A 131LEU A 55LEU A 59 | None | 0.69A | 6g9bA-5i7kA:undetectable6g9bB-5i7kA:undetectable | 6g9bA-5i7kA:14.296g9bB-5i7kA:15.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iaa | UBIQUITIN-LIKEMODIFIER-ACTIVATINGENZYME 5 (Homo sapiens) |
PF00899(ThiF) | 4 | ILE A 216VAL A 76LEU A 179LEU A 273 | None | 0.63A | 6g9bA-5iaaA:undetectable6g9bB-5iaaA:undetectable | 6g9bA-5iaaA:14.346g9bB-5iaaA:15.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5irm | UNCHARACTERIZEDPROTEIN (Oryctolaguscuniculus) |
PF05729(NACHT)PF13516(LRR_6) | 4 | LEU A 452LEU A 453LEU A 496MET A 493 | None | 0.65A | 6g9bA-5irmA:undetectable6g9bB-5irmA:undetectable | 6g9bA-5irmA:7.216g9bB-5irmA:7.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jvk | UNCHARACTERIZEDPROTEIN (Bacteroidescellulosilyticus) |
no annotation | 4 | LEU A 494VAL A 483LEU A 513LEU A 515 | None | 0.66A | 6g9bA-5jvkA:undetectable6g9bB-5jvkA:undetectable | 6g9bA-5jvkA:8.116g9bB-5jvkA:9.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ke1 | OUTER MEMBRANEPROTEIN ICSAAUTOTRANSPORTER (Shigellaflexneri) |
PF03212(Pertactin)PF12951(PATR) | 4 | LEU A 527LEU A 535LEU A 498LEU A 483 | None | 0.68A | 6g9bA-5ke1A:undetectable6g9bB-5ke1A:undetectable | 6g9bA-5ke1A:14.206g9bB-5ke1A:13.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ke1 | OUTER MEMBRANEPROTEIN ICSAAUTOTRANSPORTER (Shigellaflexneri) |
PF03212(Pertactin)PF12951(PATR) | 4 | VAL A 506LEU A 535LEU A 498LEU A 483 | None | 0.71A | 6g9bA-5ke1A:undetectable6g9bB-5ke1A:undetectable | 6g9bA-5ke1A:14.206g9bB-5ke1A:13.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l75 | FIG000988: PREDICTEDPERMEASE (Klebsiellapneumoniae) |
PF03739(YjgP_YjgQ) | 4 | ILE F 21LEU F 22LEU F 73MET F 74 | None | 0.71A | 6g9bA-5l75F:undetectable6g9bB-5l75F:undetectable | 6g9bA-5l75F:13.806g9bB-5l75F:11.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ojs | TRANSCRIPTION-ASSOCIATED PROTEIN 1 (Saccharomycescerevisiae) |
PF00454(PI3_PI4_kinase)PF02259(FAT) | 4 | LEU T1596VAL T1607LEU T1620LEU T1636 | None | 0.74A | 6g9bA-5ojsT:undetectable6g9bB-5ojsT:undetectable | 6g9bA-5ojsT:2.216g9bB-5ojsT:1.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t9t | PROTOCADHERIN GAMMAB2-ALPHA C (Mus musculus) |
PF00028(Cadherin)PF08266(Cadherin_2) | 4 | LEU A 471VAL A 520LEU A 500LEU A 502 | None | 0.71A | 6g9bA-5t9tA:undetectable6g9bB-5t9tA:undetectable | 6g9bA-5t9tA:11.756g9bB-5t9tA:8.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u9p | GLUCONATE5-DEHYDROGENASE (Burkholderiacenocepacia) |
PF13561(adh_short_C2) | 4 | LEU A 28VAL A 249LEU A 189LEU A 234 | None | 0.69A | 6g9bA-5u9pA:undetectable6g9bB-5u9pA:undetectable | 6g9bA-5u9pA:16.336g9bB-5u9pA:16.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5voc | ENVELOPEGLYCOPROTEIN L (Humanbetaherpesvirus5) |
PF01801(Cytomega_gL) | 4 | ILE B 86LEU B 82VAL B 151LEU B 126 | None | 0.71A | 6g9bA-5vocB:undetectable6g9bB-5vocB:undetectable | 6g9bA-5vocB:17.496g9bB-5vocB:16.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) |
no annotation | 4 | ILE A 25VAL A 7LEU A 35LEU A 161 | None | 0.57A | 6g9bA-5wyrA:undetectable6g9bB-5wyrA:undetectable | 6g9bA-5wyrA:25.686g9bB-5wyrA:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xog | DNA-DIRECTED RNAPOLYMERASE SUBUNIT (Komagataellaphaffii) |
PF00623(RNA_pol_Rpb1_2)PF04983(RNA_pol_Rpb1_3)PF04990(RNA_pol_Rpb1_7)PF04992(RNA_pol_Rpb1_6)PF04997(RNA_pol_Rpb1_1)PF04998(RNA_pol_Rpb1_5)PF05000(RNA_pol_Rpb1_4) | 4 | VAL A 17LEU A1412LEU A1433MET A1432 | None | 0.72A | 6g9bA-5xogA:undetectable6g9bB-5xogA:undetectable | 6g9bA-5xogA:4.276g9bB-5xogA:3.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxi | CYTOCHROME P450 2C9 (Homo sapiens) |
no annotation | 4 | LEU A 453LEU A 310LEU A 485LEU A 152 | None | 0.71A | 6g9bA-5xxiA:undetectable6g9bB-5xxiA:0.0 | 6g9bA-5xxiA:9.726g9bB-5xxiA:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5zln | TOLL-LIKE RECEPTOR 9 (Mus musculus) |
no annotation | 5 | ILE A 114LEU A 78LEU A 94LEU A 89MET A 122 | None | 1.44A | 6g9bA-5zlnA:undetectable6g9bB-5zlnA:undetectable | 6g9bA-5zlnA:16.876g9bB-5zlnA:23.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6all | FE(3+)-CITRATE-BINDING PROTEIN YFMC (Bacillusanthracis) |
PF01497(Peripla_BP_2) | 4 | LEU A 132VAL A 99LEU A 58LEU A 113 | None | 0.72A | 6g9bA-6allA:undetectable6g9bB-6allA:undetectable | 6g9bA-6allA:16.076g9bB-6allA:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ap4 | DNA POLYMERASE IIISUBUNIT BETA (Acinetobacterbaumannii) |
no annotation | 4 | LEU A 208LEU A 228LEU A 252LEU A 171 | None | 0.74A | 6g9bA-6ap4A:undetectable6g9bB-6ap4A:undetectable | 6g9bA-6ap4A:27.176g9bB-6ap4A:15.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6f5u | ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 (Zaireebolavirus) |
no annotation | 5 | ILE A 38LEU A 43VAL A 66LEU A 184LEU A 186 | NoneCQN A 610 ( 4.7A)CQN A 610 (-4.0A)CQN A 610 ( 4.6A)None | 0.50A | 6g9bA-6f5uA:36.66g9bB-6f5uA:undetectable | 6g9bA-6f5uA:100.006g9bB-6f5uA:10.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6f6s | ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN,GP1 (Zaireebolavirus) |
no annotation | 5 | ILE A 38LEU A 43VAL A 66LEU A 184LEU A 186 | None | 0.36A | 6g9bA-6f6sA:36.66g9bB-6f6sA:undetectable | 6g9bA-6f6sA:100.006g9bB-6f6sA:10.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fg8 | SOMATICEMBRYOGENESISRECEPTOR KINASE 1 (Arabidopsisthaliana) |
no annotation | 5 | LEU A 85VAL A 74LEU A 98LEU A 116LEU A 33 | None | 1.08A | 6g9bA-6fg8A:undetectable6g9bB-6fg8A:undetectable | 6g9bA-6fg8A:24.146g9bB-6fg8A:14.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fnw | VOLUME-REGULATEDANION CHANNELSUBUNIT LRRC8A (Mus musculus) |
no annotation | 4 | VAL A 562LEU A 569LEU A 593LEU A 551 | None | 0.75A | 6g9bA-6fnwA:undetectable6g9bB-6fnwA:undetectable | 6g9bA-6fnwA:20.836g9bB-6fnwA:20.88 |